Evidence map›Paper›PMID 29389067›Full record

ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2018

Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma.

Kyle T Amber, Manuel Valdebran, Yuxin Lu, Sebastien De Feraudy, Kenneth G Linden

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kyle T AmberDepartment of Dermatology, University of California Irvine, Irvine, California, USA.
Manuel ValdebranDepartment of Dermatology, University of California Irvine, Irvine, California, USA.
Yuxin LuDepartment of Pathology, University of California Irvine Medical Center, Orange, California, USA.
Sebastien De FeraudyDepartment of Dermatology, University of California Irvine, Irvine, California, USA.
Kenneth G LindenDepartment of Dermatology, University of California Irvine, Irvine, California, USA.

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Institutional Career Development CoreKL2TR001416 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI CAIOZZO, VINCENT JAMES, DEMETRIOU, MICHAEL · 2015 to 2023
$5.6M
NCATS NIH HHS KL2 TR001416NCATS NIH HHS UL1 TR001414
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Administration, OralAdministration, TopicalAged, 80 and overAntibodies, Monoclonal, HumanizedAntineoplastic AgentsBiopsyClobetasolDrug Therapy, CombinationFemaleHumansLeg DermatosesLymphatic MetastasisMelanomaNeoplasm MetastasisNeoplasm StagingPemphigoid, BullousAntibodies, Monoclonal, HumanizedAntineoplastic AgentsClobetasolpembrolizumabPrednisone

Identifiers

PMID29389067
PMCPMC6140316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.